Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02830425
Status:
COMPLETED
Last Update Posted:
2020-04-09
First Post:
2016-07-01
Brief Title:
Potentially Inappropriate Prescription Associated to Multimorbidity
Sponsor:
Corporacion Parc Tauli
Organization:
Corporacion Parc Tauli
Study Overview
Official Title:
Potentially Inappropriate Prescription Associated to Multimorbidity Using the Explicit STOPP-START Screening Tool of Older Persons Potentially Inappropriate PrescriptionsScreening Tool to Alert Doctors to the Right Treatment Criteria
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PIMyC
Brief Summary:
A prospective multicenter cohort study in 5 hospitals in Spain will be initiated in 2016
Objectives
1 To estimate and describe patterns of multimorbidity and polypharmacy in patients over 64 admitted for a chronic disease exacerbation
2 To analyze the potentially inappropriate prescribing PPI drugs according to STOPP START SS criteria
3 To evaluate the relationship between multimorbidity and PPI and adverse medication RAM preventable reaction
The cohort will include 800 patients 64 years admitted in internal medicine and or geriatric department of 5 hospitals of the National Health Service Application of the SS criteria released in 2015 on admission and at discharge and collection of demographic and clinical variables including comorbidities baseline chronic medication geriatric syndromes functional capacity and RAM Descriptive analysis and bivariate parametric or nonparametric tests will be applied to analyze relationship between morbidity polypharmacy SS criteria and RAM Intraobserver agreement will be assessed for SS criteria Multiple regression techniques will be applied where the dependent variable will be the PPI or the RAM
Objectives
1 To estimate and describe patterns of multimorbidity and polypharmacy in patients over 64 admitted for a chronic disease exacerbation
2 To analyze the potentially inappropriate prescribing PPI drugs according to STOPP START SS criteria
3 To evaluate the relationship between multimorbidity and PPI and adverse medication RAM preventable reaction
The cohort will include 800 patients 64 years admitted in internal medicine and or geriatric department of 5 hospitals of the National Health Service Application of the SS criteria released in 2015 on admission and at discharge and collection of demographic and clinical variables including comorbidities baseline chronic medication geriatric syndromes functional capacity and RAM Descriptive analysis and bivariate parametric or nonparametric tests will be applied to analyze relationship between morbidity polypharmacy SS criteria and RAM Intraobserver agreement will be assessed for SS criteria Multiple regression techniques will be applied where the dependent variable will be the PPI or the RAM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None